A fungal-fermentation byproduct from Aspergillus oryzae (the same organism behind sake) that inhibits tyrosinase — the rate-limiting enzyme in melanin synthesis. Long a Japanese and Korean staple, now mainstream in U.S. brightening stacks (Topicals, Tatcha-adjacent formulations). The 2025 conversation hedges around stability and irritation potential at higher doses.
Benefits
tyrosinase inhibitor — direct melanogenesis brake
fermentation-derived, vegan
stacks with TXA, vitamin C, and niacinamide
Example uses
dark-spot serums
brightening masks
melasma support protocols
Mechanism of action
A fungal-fermentation metabolite (γ-pyrone) from Aspergillus oryzae that competitively inhibits tyrosinase — the rate-limiting copper-containing enzyme in melanogenesis — by chelating the active-site copper ions. Distinct from arbutin or hydroquinone in mechanism: kojic locks the enzyme rather than substituting for the substrate. Also a respectable iron chelator and ROS scavenger, contributing antioxidant load beyond the brightening claim. Sensitisation risk above 2% is a known dose-response phenomenon attributed in part to the same metal-chelating chemistry that drives efficacy.
Clinical evidence · Moderate
Decades of clinical work in Japan and Korea on melasma and PIH; effect sizes are real but slower-onset than hydroquinone; meta-analyses support efficacy at 1–4% over 8–12 weeks.
Effective concentration range
1–4% (free acid); kojic dipalmitate at 2–5% for improved stability
Formulation notes
Effective at 1–4%. Pairs well with TXA and azelaic acid for multi-pathway brightening. Stability is poor in light/water systems — kojic dipalmitate is the preferred stabilized derivative.
Watchouts
Sensitization risk above 2%; can cause contact dermatitis in repeated use. EU monitors kojic for further restriction. Pure kojic acid oxidizes to brown — discoloration of the formula = lost activity.
The EU SCCS has reviewed kojic for further restriction multiple times; current opinion permits up to 1% in face and hand products with sensitisation flagged as the concern. Pure kojic oxidises to brown rapidly — colour change in a serum is a direct activity-loss signal that brands rarely communicate. Counterfeit and adulterated 'kojic acid soap' is a recurring problem in informal Asian and African markets.
Market positioning
Sold as the gentler, fermentation-derived alternative to hydroquinone — and clinically it largely is, with the trade-off of slower onset. Increasingly stacked with TXA, niacinamide, and azelaic in multi-pathway brightening routines that outperform single-active approaches.
Mostly trusted — biotech-fermented credibility — but watch for clean brands quietly switching to kojic dipalmitate (a derivative) and labeling as kojic.